Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia

Blood

Volumn 94, Issue 11, 1999, Pages 3717-3721

  Aguayo, Alvaro ^b   Estey, Elihu ^b   Kantarjian, Hagop ^b   Mansouri, Taghi ^b   Gidel, Cristi ^b   Keating, Michael ^b   Giles, Francis ^b   Estrov, Zeev ^b   Barlogie, Bart ^b   Albitar, Maher ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANGIOGENESIS; ARTICLE; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; TUMOR GROWTH;

EID: 0033485961     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3717     Document Type: Article

References (31)

1. Thomas KA: Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603, 1996
2. Fox SB: Tumour angiogenesis and prognosis. Histopathology 30:294, 1997
3. Vincenti V, Cassano C, Rocchi M, Persico G: Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493, 1996
4. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947, 1991
5. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 32A:2413, 1996
6. Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T: Clinical significance of the determination of angiogenic factors. Eur J Cancer 32A:2513, 1996
7. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851, 1989
8. Plouet J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8:3801, 1989
9. Pepper MS, Wasi S, Ferrara N, Orci L, Montesano R: In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 210:298, 1994
10. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244, 1992
11. Jakeman LB, Armanini M, Phillips HS, Ferrara N: Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133:848, 1993
12. Folkman J: Tumor angiogenesis, in Mendelsohon J, Howley PM, Israel MA, Liotta LA (eds): The Molecular Basis of Cancer. Philadelphia, PA, Saunders, 1995, p 206
13. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl Med 285:1182, 1971
14. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27, 1995
15. Folkman J: Tumor Angiogenesis, in Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR (eds): Cancer Medicine, vol 1. Philadelphia, PA, Lea & Febiger, 1993, p 153
16. Folkman J: Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333:1757, 1995
17. Folkman J: What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82:4, 1990
18. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55:510, 1995
19. Toi M, Hoshina S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85:1045, 1994
20. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964, 1995
21. Salven P, Ruotsalairen T, Mattson K, Joensuu H: High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer 79:144, 1998
22. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306, 1989
23. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J: Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150:815, 1997
24. Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M, Hossfeld DK: Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89:1870, 1997
25. Starostik P, Manshouri T, O'Brien S, Freireich E, Kantarjian H, Haidar M, Lerner S, Keating M, Albitar M: Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res 58:4552, 1998
26. Fleming TR, Harrington DP: Counting Processes and Survival Analysis. New York, NY, Wiley, 1991
27. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515, 1994
28. Cleveland WS: Robust locally-weighted regression and smoothing scatterplots. J Am Stat Assoc 74:829, 1979
29. Seeker RA, Chambers JM, Wilks AR: The New S Language. Pacific Grove, CA, Wadsworth, 1988
30. Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M: Effect of diagnosis (RAEB, RAEB-t, or AML) on outcome of AML-type chemotherapy. Blood 90:2969, 1997
31. Estey EH, Thall PF, Pierce S, Cortes J, Beran M, Kantarjian H, Keating MJ, Andreeff M, Freireich E: Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin ± all-trans retinoic acid ± granulocyte-colony stimulating factor in poor prognosis newly-diagnosed non-APLAML and MDS. Blood 93:2478, 1999